US FDA grants priority voucher to J&J's blood cancer treatment

The U.S. Food and Drug Administration said on Monday it has granted a national priority voucher to Johnson & Johnson's blood ...
Becker's Hospital Review

5 FDA moves reshaping US drug policy

FDA moves reshaping drug policy include fast-track programs, updated biosimilar guidance, and new rare disease approval pathways.

Exclusive-US FDA brass pushed internally for speedier Lilly weight-loss pill verdict

Food and Drug Administration have pressed internally for reviewers to speed up their evaluation of Eli Lilly's experimental ...

US FDA approves first at-home device for depression

The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, ...

US FDA launches fresh safety scrutiny of approved RSV therapies for infants

U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective RSV treatments for infants would face fresh safety scrutiny following ...
Scientific American

U.S. Sunscreens Aren’t Great. The FDA Could Soon Change That

The U.S. is considering allowing bemotrizinol, a highly effective UV filter used throughout Europe and Asia, in its sunscreen products for the first time ...

US FDA approves first drug under new fast-track review program

The U.S. Food and Drug Administration approved on Tuesday the first drug under its new fast-track program designed to shorten ...
FiercePharma

Amid Trump admin's drug pricing push, FDA aims to give biosimilars a boost

The FDA has revealed a set of measures designed to increase the availability of biosimilars in the U.S. and in turn reduce the price of biologic medicines after they lose patent protection. In new ...